Cargando…
GBP2 acts as a member of the interferon signalling pathway in lupus nephritis
Lupus nephritis (LN) is a common and serious clinical manifestation of systemic lupus erythematosus. However, the pathogenesis of LN is not fully understood. The currently available treatments do not cure the disease and appear to have a variety of side effects in the long term. The purpose of this...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482746/ https://www.ncbi.nlm.nih.gov/pubmed/36115937 http://dx.doi.org/10.1186/s12865-022-00520-5 |